Posts

New paper proposes standards – and actionable clinical ...

A new paper led by Harvard researchers has zeroed in on biomarkers of aging usin...

Harnessing light with hemispherical shells

In the pursuit of sustainable energy solutions, the quest for more efficient sol...

Targeting ‘undruggable’ proteins promises new approach ...

Researchers led by Northwestern University and the University of Wisconsin-Madis...

Rare case of opossum infected by rabies sounds alarm re...

A female White-eared opossum (Didelphis albiventris) found dead in 2021 in Bosqu...

Study finds risk-reducing mastectomy (RRM) may lower br...

A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of ...

Combating fractional spurs in phase locked loops to imp...

Two innovative design techniques lead to substantial improvements in performance...

Sylvester appoints prominent oncologist-researcher to l...

MIAMI, FLORIDA (Feb. 15, 2024) – Prominent oncologist and researcher Damian Gree...

Scientists try out stone age tools to understand how th...

Tokyo, Japan – Researchers from Tokyo Metropolitan University crafted replica st...

Takeda Bags FDA Approval For Esophagus Inflammation The...

The U.S. Food and Drug Administration (FDA) has given the green light to Eohilia...

Trial for Gritstone’s BARDA-funded COVID-19 vaccine del...

Gritstone Bio has secured a substantial sum of $433 million in federal funding e...

Biotech Firm LianBio Announces Winding Down Operations

LianBio, a significant player in the biotech industry based in Shanghai, has rec...

Dragonfly and Gilead enter partnership for cancer therapy

Dragonfly Therapeutics has entered a clinical collaboration with Gilead Sciences...

FDA grants orphan drug status to Ionis’ olezarsen for F...

The US FDA has granted orphan drug designation to Ionis Pharmaceuticals’ olezars...

Xyphos and Kelonia link for immuno-oncology drug develo...

Xyphos Biosciences has entered an agreement with Kelonia Therapeutics to develop...

GSK concludes Aiolos Bio acquisition for $1.4bn

GSK has successfully concluded the acquisition of Aiolos Bio in a deal that coul...

Psychedelic treatments for mental health: Is there subs...

The success of recent trials treating mental health problems with psychedelic th...